High-dose methadone in pregnant women and its effect on duration of neonatal abstinence syndrome

被引：50
|
作者：
Lim, Susie [4 ]
Prasad, Mona R. [1 ]
Samuels, Philip [1 ]
Gardner, Debra K. [2 ]
Cordero, Leandro [3 ]
机构：
[1] Ohio State Univ, Med Ctr, Dept Obstet & Gynecol, Columbus, OH 43210 USA
[2] Ohio State Univ, Med Ctr, Dept Pharm, Columbus, OH 43210 USA
[3] Ohio State Univ, Med Ctr, Dept Pediat, Columbus, OH 43210 USA
[4] Kaiser Permanente NW, Dept Obstet & Gynecol, Beaverton, OR 97005 USA
来源：
AMERICAN JOURNAL OF OBSTETRICS AND GYNECOLOGY | 2009年 / 200卷 / 01期
关键词：
breastfeeding; methadone; neonatal abstinence syndrome; neonatal withdrawal; MAINTENANCE; SEVERITY; MILK;
D O I：
10.1016/j.ajog.2008.08.041
中图分类号：
R71 [妇产科学];
学科分类号：
100211 ;
摘要：
OBJECTIVE: The purpose of this study was to examine high-dose methadone in pregnant women and its effect on the duration of neonatal abstinence syndrome. STUDY DESIGN: This was a retrospective chart review of 68 neonates and their mothers who received methadone therapy during pregnancy. The last dosage of maternal methadone just before delivery and the length of treatment for neonatal abstinence syndrome were examined with an analysis of variance model. RESULTS: When the data were analyzed for methadone dosages as a continuous variable, each 1-mg increase in the last maternal methadone dosage before delivery was associated with an additional 0.18 days of infant treatment for neonatal abstinence syndrome (P < .001; 95% CI, 0.112-0.255). In other words, every increase of 5.5 mg of methadone in the mother was associated statistically with 1 additional day of neonatal abstinence syndrome treatment for the infant. Gestational age at delivery and birthweight were not statistically significant. CONCLUSION: Higher doses of maternal methadone were associated with an increase in diagnosis and longer duration of neonatal abstinence syndrome.
引用
收藏
页码：70.e1 / 70.e5
页数：5
相关论文
共 50 条
  • [21] Buprenorphine versus methadone in the treatment of pregnant opioid-dependent patients: effects on the neonatal abstinence syndrome
    Jones, HE
    Johnson, RE
    Jasinski, DR
    O'Grady, KE
    Chisholm, CA
    Choo, RE
    Crocetti, M
    Dudas, R
    Harrow, C
    Huestis, MA
    Jansson, LM
    Lantz, M
    Lester, BM
    Milio, L
    DRUG AND ALCOHOL DEPENDENCE, 2005, 79 (01) : 1 - 10
  • [22] Perinatal risk factors for the neonatal abstinence syndrome in infants born to women on methadone maintenance therapy
    Liu, Anthony J. W.
    Jones, Michael P.
    Murray, Henry
    Cook, Colleen-Maree
    Nanan, Ralph
    AUSTRALIAN & NEW ZEALAND JOURNAL OF OBSTETRICS & GYNAECOLOGY, 2010, 50 (03): : 253 - 258
  • [23] MATERNAL AND FETAL METHADONE EXPOSURE: ASSOCIATIONS WITH NEONATAL ABSTINENCE SYNDROME
    Metzger, I. F.
    Schwartz, A. E.
    Haneline, L. S.
    Haas, D. M.
    Evrard, C. A.
    Yeley, B. C.
    Jones, D. R.
    Masters, A. R.
    Renbarger, J. L.
    Quinney, S. K.
    CLINICAL PHARMACOLOGY & THERAPEUTICS, 2017, 101 (S1) : S99 - S99
  • [24] Treatment of neonatal abstinence syndrome with breast milk containing methadone
    Ballard, JL
    JOURNAL OF PERINATAL & NEONATAL NURSING, 2002, 15 (04) : 76 - 85
  • [25] Morphine vs Methadone Treatment for Infants with Neonatal Abstinence Syndrome
    Tolia, Veeral N.
    Murthy, Karna
    Bennett, Monica M.
    Greenberg, Rachel G.
    Benjamin, Daniel K.
    Smith, P. Brian
    Clark, Reese H.
    JOURNAL OF PEDIATRICS, 2018, 203 : 185 - 189
  • [26] USE OF METHADONE IN TREATMENT OF NEONATAL ABSTINENCE SYNDROME: LITERATURE REVIEW
    Nedungadi, S.
    Johnson, K.
    INTENSIVE CARE MEDICINE, 2011, 37 : S410 - S410
  • [27] Neonatal Abstinence Syndrome and Ethical Approaches to the Identification of Pregnant Women Who Use Drugs
    Terplan, Mishka
    Minkoff, Howard
    OBSTETRICS AND GYNECOLOGY, 2017, 129 (01): : 164 - 167
  • [28] Opioid Utilization by Pregnant Women with Sickle Cell Disease and the Risk of Neonatal Abstinence Syndrome
    Nnoli, Aisha
    Seligman, Neil S.
    Dysart, Kevin
    Baxter, Jason K.
    Ballas, Samir K.
    JOURNAL OF THE NATIONAL MEDICAL ASSOCIATION, 2018, 110 (02) : 163 - 168
  • [29] Ondansetron Pharmacokinetics in Pregnant Women and Neonates: Towards a New Treatment for Neonatal Abstinence Syndrome
    Elkomy, M. H.
    Sultan, P.
    Carvalho, B.
    Peltz, G.
    Wu, M.
    Clavijo, C.
    Galinkin, J. L.
    Drover, D. R.
    CLINICAL PHARMACOLOGY & THERAPEUTICS, 2015, 97 (02) : 167 - 176
  • [30] Ultrarapid high-dose methadone detoxification
    Isidro J. Prieto
    Rosa Poyo-Guerrero
    Ricardo Fernández
    Enriqueta Ochoa
    Psychopharmacology, 2003, 165 : 430 - 430
12345